The results of a recent clinical trial has found a potential new treatment option for nicotine addiction, and it’s available at pharmacies.
The study, led by Monash University… found smokers treated with both varenicline (Champix) and nicotine lozenges had an 84% higher chance of quitting than those taking varenicline alone. Smokers are advised to consult their GP before starting any treatment
Produced By: Zachary Probert
Featured In Story: Associate Professor Johnson George – Lecturer in Pharmacy Practice at Monash University
First aired on The Wire, Monday 1 July 2024